ClinicalTrials.Veeva

Menu

Freezing of Gait - Clinical Outcomes Assessment (FOG-COA)

T

Tel Aviv Sourasky Medical Center

Status

Enrolling

Conditions

PD - Parkinson's Disease

Treatments

Device: Opals
Device: Axivity

Study type

Observational

Funder types

Other

Identifiers

NCT06519279
0608-23-TLV

Details and patient eligibility

About

To develop a reliable and accurate clinician-reported outcome (ClinRO) measure (against a new and precise definition) and patient reported outcome (PRO) for use by clinicians and researchers to quantify the severity of Freezing of Gait (FOG).

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Diagnosis of idiopathic Parkinson's disease (PD) made by a neurologist according to the Movement Disorders Society guidelines;
  2. Able to walk independently for a distance of 10 meters, without walking aid;
  3. Absence of a Deep Brain Stimulator;
  4. Stable PD treatment in the 4 weeks prior to participation that is not expected to change in the course of the study.
  5. For patients with FOG: a score of ≥ 1 on the New Freezing Of Gait Questionnaire (NFOG-Q).

Exclusion criteria

  1. Occurrence of any of the following within 3 months prior to informed consent: myocardial infarction, hospitalization for unstable angina, stroke, coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), implantation of a cardiac resynchronization therapy device (CRTD), active treatment for cancer or other malignant disease, uncontrolled congestive heart disease (NYHA class >3), acute psychosis or major psychiatric disorders or continued substance abuse, other neurological (than PD) or orthopaedic impairment that significantly impacts on gait.
  2. Unwilling to temporarily delay the morning anti-Parkinsonian medication.
  3. Preganacy and

Trial design

20 participants in 2 patient groups

Freezing Of Gait Patients
Description:
15 patients with Parkinson disease with freezing of gait (group) in ON \& OFF states
Treatment:
Device: Axivity
Device: Opals
Non Freezing Of Gait Patients
Description:
5 patients with Parkinson disease without freezing of gait (cohort) in ON \& OFF states
Treatment:
Device: Axivity
Device: Opals

Trial contacts and locations

1

Loading...

Central trial contact

Jeffery Hausdorff, Professor; Omri Batori, B.sc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems